Global Peptic Ulcer Testing Market Size, Share, Forecast Report, 2020-2027

The global peptic ulcer testing market is projected to grow at the CAGR of 5.5% during the forecast period. The growth of the market is backed by the increasing incidences of stomach cancer coupled with the changing lifestyle & food habits such as untimely meal patterns, excess consumption of fatty foods, chronic acidity and food poisoning. As per the American Cancer Society, around 27,510 cases of stomach cancer are estimated to be diagnosed in the US in 2019. Such a scenario has raised the need for faster and accurate diagnosis of peptic ulcer testing. The most commonly occurring stomach disease called peptic ulcer is primarily caused by sores and lesions owing to the excess secretion of the hydrochloric acid and the pepsin enzyme from the histamine cells into the gastrointestinal tract.

This disease generally occurs owing to the H. pylori (Helicobacter pylori) bacterium, however, can also be caused by long term usage of the non-steroidal anti-inflammatory drugs. Whereas in rare cases peptic ulcers can also occur due to the presence of some specific illness or inheritance. However, only 10-15% of Helicobacter pylori-positive cases develop peptic ulcers but up to 90% of all peptic ulcers occur owing to H. pylori. In developing and underdeveloped countries, the prevalence of peptic ulcers is greater than in developed countries. This fact is supported by the presence of a high population within developing countries that are suffering from this disease and requires treatment thus, creating demand for peptic ulcer testing market.

The other key factors that are driving the growth of the global market are the growing usage of rapid urease test for h. pylori detection and development of advanced & new testing techniques. However, medical reimbursement issues related to certain tests in some countries are currently hampering the growth of the global peptic ulcer testing market.

Segmental Outlook

The market is segmented on the basis of the diagnostic tests and end-user. On the basis of end-user, the market is segregated into hospitals, laboratories, and others. The diagnostic laboratories segment is projected to account for a major market share in the peptic ulcer testing market, followed by the hospitals segment, and others. The number of diagnostic laboratories is rapidly increasing across the globe. An increase in diagnostic laboratories can contributed to a significant number of tests being carried out in single, standalone and hospital-affiliated laboratories owing to their capability to handle a high volume of tests.

A Urea Breath test will be the largest segment by diagnostic tests

On the basis of diagnostic tests, the market is segmented into endoscopy, upper gastrointestinal series, laboratory test such as blood tests, Elisa tests, urea breath tests, stool tests, and other tests. The urea breath tests segment is anticipated to grow at the significant growth over the forecast period. The growth of this segment is attributed to the test's accuracy and growing availability. This test is performed by using an isotope that is rarely available. Therefore, R&D is going on to make the isotope readily available in hospitals and laboratories.

Regional Outlook

The global peptic ulcer testing market is further segmented on the basis of geography including North America, Europe, Asia-Pacific and Rest of the World. In 2018, Asia-Pacific is expected to hold the significant market share in terms of rapid tests for H. pylori across the globe. Whereas in terms of revenue generation, North America is expected to have significant market size in the global peptic ulcer testing market owing to the increase in the number of people suffering from peptic ulcer. As per the estimation of National Center for Biotechnology Information (NCBI), in the US, around 5 million individuals are affected by a peptic ulcer at any given time. A peptic ulcer is an important cause of the morbidity and healthcare costs; estimates of expenditures related to hospitalization, work loss and outpatient care (excluding medication costs) totaled around $5.65 billion per year in the US. North America is followed by Europe and the Asia-Pacific is expected to be the fastest-growing market during the forecast period.

Asia-Pacific will augment with the highest growth rate in peptic ulcer testing market

Asia-Pacific is expected to witness the highest growth rate during the forecast period. In Asia-Pacific region, the incidence of peptic ulcer disease is quite high as most countries within this region are developing or under-developed and have relatively poor sanitation & hygienic condition which results in a rise to contracting H. pylori infections. As per WHO, peptic ulcer disease deaths reached 57,658 in India in 2017. The age-adjusted death rate due to peptic ulcer disease in India is 5.79 per 100,000 people who have ranked India #53 across the globe. Such a fact states the high incidence rate of peptic ulcer disease which has widened the scope for the growth of the peptic ulcer testing market in the Asia-Pacific.

Market Players Outlook

The key players of peptic ulcer testing market include Kibion AB, Beckman Coulter Inc., Biomerieux S.A., Otsuka America Pharmaceutical, Inc., Becton, Dickinson, and Company, Quidel Corporation and Meridian Bioscience Inc. Merger & acquisition, product launch, strategic alliances, and partnerships are the key strategies adopted by the market players. For Instance, in July 2018, biomerieux had acquired Suzhou Hybiome Biomedical Engineering Co. Ltd. This acquisition was done to diversify the product portfolio of bioMerieux by including two automated, mid-throughput immunoassay systems (AE-180 and AE-240) of Hybiomein its product line.